A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates
Mitchell S. Cairo(New York Medical College), Avroy A. Fanaroff(Rainbow Babies & Children's Hospital), Tulika Seth(Manipal Academy of Higher Education), Mirjana Nesin(Children's Hospital of Orange County), J Laver(Children's Hospital of Orange County), Carmella van de Ven(Children's Hospital of Orange County), Jan M. Agosti, Bhagya L. Puppala(Children's Hospital of Orange County), J. Gary Wheeler(Children's Hospital of Orange County), Laurence B. Givner(Children's Hospital of Orange County), R Ellis(Children's Hospital of Orange County)
Cited by 74
Related Papers
Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy
|New England Journal of Medicine|2005|2.8k
Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network
|PEDIATRICS|2002|2.4k
Very Low Birth Weight Outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 Through December 1996
|PEDIATRICS|2001|1.5k
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
|New England Journal of Medicine|1996|1.3k